Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
In this study the investigators will recruit hypertensive subjects with higher than average
uric acid levels to test the effect of lowering uric acid with febuxostat on several measures
as listed below. This will be a randomized, double-blind, placebo-controlled, parallel group
study.